1. Academic Validation
  2. Development of xanthone derivatives as effective broad-spectrum antimicrobials: Disrupting cell wall and inhibiting DNA synthesis

Development of xanthone derivatives as effective broad-spectrum antimicrobials: Disrupting cell wall and inhibiting DNA synthesis

  • Sci Adv. 2025 Mar 7;11(10):eadt4723. doi: 10.1126/sciadv.adt4723.
Haizhou Li 1 Wen-Tyng Kang 1 Yujiahui Zheng 1 Yonglv He 1 Rongcui Zhong 1 Shanfang Fang 1 Weijie Wen 1 Shouping Liu 1 Shuimu Lin 1
Affiliations

Affiliation

  • 1 Guangdong Provincial Key Laboratory of Molecular Target and Clinical Pharmacology, School of Pharmaceutical Sciences and the Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Guangzhou 511436, China.
Abstract

Discovering potent Antibiotics is of critical importance due to the substantial increases of microbial resistance. Xanthones are intriguing sources of antimicrobials, despite a scarcity of extensive investigations into their mechanisms of action. Here, we reported the development of a series of xanthone derivatives, among which compound XT17 displayed strong broad-spectrum Antibacterial activity, weak hemolytic activity, and low cytotoxicity against mammalian cell lines, low frequencies of drug resistance, and potent in vivo efficacy in Staphylococcu aureus- or Pseudomonas aeruginosa-induced murine corneal Infection models. Compound XT17 presented a multifaceted mode of actions, involving the disruption of cell wall by interacting with lipoteichoic acid or lipopolysaccharides and the suppression of DNA synthesis. A further docking study confirmed the capability of compound XT17 to form a stable complex with the Bacterial gyrase Enzyme. This work could offer an innovative design strategy for developing broad-spectrum therapeutic agents against drug-resistant bacteria.

Figures
Products